1 Association of Blood Pressure Classification in Young Adults Using the 2017 American College of Cardiology/American Heart Association Blood Pressure Guideline With Cardiovascular Events Later in Life

2 effects of erythropoiesis-stimulating agents on heart failure patients with anemia: a meta-analysis

3 relationship between advanced glycation end-products with the severity of chronic heart failure in 85 patients

4 Composition and cardioprotective effects of Primula veris L. solid herbal extract in experimental chronic heart failure.

5 Differential diagnosis and clinical management of diastolic heart failure: current best practice

6 Guideline-recommended therapy, including beta-blocker utilization, in patients with chronic heart failure: results from a Canadian community hospital heart function clinic

7 Hyperkalemia in heart failure patients: current challenges and future prospects

8 Improving medication adherence of patients with chronic heart failure: challenges and solutions

9 Acute decompensated heart failure: current pharmacological approaches

10 Ventricular assist devices for heart failure: a focus on patient selection and complications

11 Current treatments for acute heart failure: focus on serelaxin

12 Copeptin in heart failure

13 SERCA2a: its role in the development of heart failure and as a potential therapeutic target

14 Galectin-3: clinical utility and prognostic value in patients with heart failure

15 Renal dysfunction prevalence and clinical impact in heart failure

16 Meta-analysis of B-type natriuretic peptide in diagnosis of congestive heart failure in different clinical settings

17 Differential diagnosis and clinical management of diastolic heart failure: current best practice

18 Guideline-recommended therapy, including beta-blocker utilization, in patients with chronic heart failure: results from a Canadian community hospital heart function clinic

19 Hyperkalemia in heart failure patients: current challenges and future prospects

20 Improving medication adherence of patients with chronic heart failure: challenges and solutions

21 Acute decompensated heart failure: current pharmacological approaches

22 Ventricular assist devices for heart failure: a focus on patient selection and complications

23 Current treatments for acute heart failure: focus on serelaxin

24 Copeptin in heart failure

25 SERCA2a: its role in the development of heart failure and as a potential therapeutic target

26 Galectin-3: clinical utility and prognostic value in patients with heart failure

27 Renal dysfunction prevalence and clinical impact in heart failure

28 Meta-analysis of B-type natriuretic peptide in diagnosis of congestive heart failure in different clinical settings

29 20-year trends in cause-specific heart failure outcomes by sex, socioeconomic status, and place of diagnosis: a population-based study

30 Data supporting the angiotensin II activates MEL18 to deSUMOylate HSF2 for hypertension-related heart failure

31 Hyponatremia in Heart Failure.

32 Emotion regulation in patients with heart failure: Its relationship with depressive symptoms and rehospitalization.

33 The place of ARBs in heart failure therapy: is aldosterone suppression the key?

34 Age-Related Characteristics and Outcomes of Patients With Heart Failure With Preserved Ejection Fraction.

35 Performance of Prognostic Heart Failure Models in Patients With Nonischemic Cardiomyopathy Undergoing Ventricular Tachycardia Ablation.

36 Long-term risk of congestive heart failure in younger breast cancer survivors: A nationwide study by the SMARTSHIP group.

37 Factors Affecting Health Care Engagement of Patients With End-Stage Heart Failure: An Exploratory Survey Study.

38 Coping in patients with heart failure

39 Impact of Simulated Hyperventilation and Periodic Breathing on Sympatho-Vagal Balance and Hemodynamics in Patients with and without Heart Failure.

40 Hemodynamic Effects of Late Sodium Current Inhibitors in a Swine Model of Heart Failure.

41 Patient Commitment to Health (PACT-Health) in the Heart Failure Population: A Focus Group Study of an Active Communication Framework for Patient-Centered Health Behavior Change.

42 Coronary Artery Bypass Graft Surgery Improves Survival Without Increasing the Risk of Stroke in Patients with Ischemic Heart Failure in Comparison to Percutaneous Coronary Intervention: A Meta-Analysis With 54,173 Patients.

43 Ventilatory Efficacy After Transcatheter Aortic Valve Replacement Predicts Mortality and Heart Failure Events in Elderly Patients.

44 Socioeconomic Factors and Clinical Outcomes Among Patients With Heart Failure in a Universal Health Care System.

45 Risk assessment of post-discharge mortality among recently hospitalized Medicare heart failure patients with reduced or preserved ejection fraction.

46 Virtual Reality for Informal Caregivers of Heart Failure Patients: A Mixed Method Research Proposal

47 Augmented fear bradycardia in rats with heart failure.

48 Augmented fear bradycardia in rats with heart failure

49 Measuring Fear of Physical Activity in Patients with Heart Failure

50 RETRACTED: Peripheral "Right to Right" Extracoporeal Membrane Oxygenation for Right Heart Failure Following Left Ventricular Assist Device Insertion.

51 [Impact of a Home Return Assistance Service (PRADO-IC) on the re-hospitalisation rate for heart failure patients].

52 The NADPH oxidase inhibitor apocynin improves cardiac sympathetic nerve terminal innervation and function in heart failure.

53 Inhaled Prostacyclin on Exercise Echocardiographic Cardiac Function in Preserved Ejection Fraction Heart Failure.

54 Immuno-Spin Trapping-Based Detection of Oxidative Modifications in Cardiomyocytes and Coronary Endothelium in the Progression of Heart Failure in Tgαq*44 Mice

55 Modelling the lifetime cost-effectiveness of catheter ablation for atrial fibrillation with heart failure.

56 [The elderly patient with heart failure: usefulness of cardiac ultrasound in routine clinical practice].

57 The Impact of Pharmacist-Based Services Across the Spectrum of Outpatient Heart Failure Therapy.

58 Cognitive impairment in heart failure is associated with altered Wnt signaling in the hippocampus.

59 Neurocognitive Disorders in Heart Failure: Novel Pathophysiological Mechanisms Underpinning Memory Loss and Learning Impairment.

60 Albumin-to-creatinine ratio as a predictor of all-cause mortality and hospitalization of congestive heart failure in Chinese elder hypertensive patients with high cardiovascular risks

61 Ecstasy induced acute systolic heart failure and Non-Ischemic Cardiomyopathy in a young female: a rare case report and literature review.

62 Differential expression of genes participating in cardiomyocyte electrophysiological remodeling via membrane ionic mechanisms and Ca-handling in human heart failure.

63 Evaluation of drugs used in chronic heart failure at tertiary care centre: a hospital based study.

64 "Future Patient" Telerehabilitation for Patients With Heart Failure: Protocol for a Randomized Controlled Trial.

65 Visual Analytics for Congestive Heart Failure Mortality Prediction.

66 Cardiac resynchronization therapy in patients with heart failure and moderately reduced ejection fraction: Could it trigger a super-response?

67 Cardiac resynchronization therapy by left bundle branch area pacing in heart failure patients with left bundle branch block.

68 Recovery of complete left bundle branch block following heart failure improvement by left bundle branch pacing in a patient

69 Atrial fibrillation incidence and impact of biventricular pacing on long-term outcome in patients with heart failure treated with cardiac resynchronization therapy

70 Cardiac Resynchronization Therapy Defibrillator Treatment in a Child with Heart Failure and Ventricular Arrhythmia

71 [Snapshot evaluation of heart failure in Turkey: Baseline characteristics of SELFIE-TR].

72 Economic burden of heart failure: investigating outpatient and inpatient costs in Abeokuta, Southwest Nigeria.

73 Histoplasmosis, heart failure, hemolysis and haemophagocytic lymphohistiocytosis.

74 Perspectives on Implementing a Multidomain Approach to Caring for Older Adults With Heart Failure.

75 Effectiveness of drug interventions to prevent sudden cardiac death in patients with heart failure and reduced ejection fraction: an overview of systematic reviews.

76 Collaboration and new data in ACTION: a learning health care system to improve pediatric heart failure and ventricular assist device outcomes.

77 Multiparametric risk stratification in patients with mild to moderate chronic heart failure.

78 The cardiopulmonary exercise test is safe and reliable in elderly patients with chronic heart failure.

79 Prevalence and prognosis of respiratory muscle weakness in heart failure patients with preserved ejection fraction.

80 Selenium and outcome in heart failure.

81 Relation of Low Triiodothyronine Syndrome Associated With Aging and Malnutrition to Adverse Outcome in Patients With Acute Heart Failure.

82 A cross-cultural comparison of the roles of emotional intelligence, metacognition, and negative coping for health-related quality of life in German versus Pakistani patients with chronic heart failure

83 Comparative Effectiveness of Sacubitril-Valsartan Versus ACE/ARB Therapy in Heart Failure With Reduced Ejection Fraction.

84 Non-cardiac-related morbidity, mobility limitation, and outcomes in older adults with heart failure.

85 Outcomes Before and After the Recall of a Heart Failure Pacemaker.

86 Acute care costs of patients admitted for management of chronic obstructive pulmonary disease exacerbations: contribution of disease severity, infection and chronic heart failure.

87 Using Lean to Enhance Heart Failure Patient Identification Processes and Increase Core Measure Scores.

88 Overexpression of mitochondrial creatine kinase preserves cardiac energetics without ameliorating murine chronic heart failure.

89 Influence of renal impairment on myocardial function in outpatients with systolic heart failure: an echocardiographic and cardiac biomarker study.

90 Association of patient-reported outcomes and heart rate trends in heart failure: a report from the Chiron project.

91 Development and feasibility testing of an education program to improve knowledge and self-care among Aboriginal and Torres Strait Islander patients with heart failure.

92 An overview of hypertension and cardiac involvement in Asia: Focus on heart failure.

93 Religious beliefs and well-being and distress in congestive heart failure patients.

94 Computer-aided diagnosis of congestive heart failure using ECG signals - A review.

95 Economic impact of heart failure with preserved ejection fraction: insights from the ALDO-DHF trial.

96 Unraveling the Molecular Mechanism of Action of Empagliflozin in Heart Failure With Reduced Ejection Fraction With or Without Diabetes.

97 Machine-learning facilitates selection of a novel diagnostic panel of metabolites for the detection of heart failure

98 Perceived benefits of the disease: A qualitative study of patients' experiences of heart failure.

99 Reducing Readmissions for Heart Failure.

100 Multi-level models for heart failure patients' 30-day mortality and readmission rates: the relation between patient and hospital factors in administrative data.

101 Higher doses of loop diuretics limit uptitration of angiotensin-converting enzyme inhibitors in patients with heart failure and reduced ejection fraction.

Keyword Connections

Journals

Research Groups

Bibliographies